LumiraDx · pitchdeck
LumiraDx | Investor Presentation Deck | 55 slides
55 pages · 3 arc beats · 2 loops
LumiraDx | Investor Presentation Deck | 55 slides
LumiraDx · 2022-09 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
12468101214161820222426283032343638404244464850525455
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 14 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 3 slides 100% 3/3 slides 100% 3/3 slides · 11 hits — 0/3 slides
— 0/3 slides
33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Solution (Provide relief) 5 slides 100% 5/5 slides 100% 5/5 slides · 19 hits — 0/5 slides
40% 2/5 slides 40% 2/5 slides 100% 5/5 slides — 0/5 slides
Evidence 6 slides 100% 6/6 slides 100% 6/6 slides · 25 hits — 0/6 slides
100% 6/6 slides · 7 hits 33.3% 2/6 slides 100% 6/6 slides — 0/6 slides
Slide inventory
55 every slide · same image gating as the playbook
01
Exhibit 99.1 indicates this is likely a regulatory or investor relations document.front_matter
03
The slide uses a list-based summary format to establish company credibility and current operational scale.summarize
04
The slide uses a combination of headshots with titles and a logo grid to establish credibility.other
05
The slide features the LumiraDx device on the right and a series of test cartridge icons on the left.establish_context
06
The slide presents a snapshot of company growth from 2019 to Q2 2022, including instrument shipments, manufacturing capacity, market reach, and revenue.summarize
07
The chart uses a waterfall-style visualization to show segments contributing to a total market size.size_opportunity
08
Uses a process flow diagram to contrast current state (central lab) vs future state (POC).frame_problem
09
The slide uses a list of pain points on the left and illustrative examples of existing POC devices on the right.frame_problem
10
Uses a photo of a lab bench to illustrate the 'proliferation of instruments' pain point.frame_problem
12
The slide uses a color-coded border system to distinguish between test types (Qualitative/Quantitative Immunoassay, Enzyme, Molecular).present_solution
Open slide detailBeat · Solution (Provide relief)
13
The chart uses a Gantt-style visualization to show progress across different diagnostic modalities.plan_implementation
Open slide detailBeat · Solution (Provide relief)
14
The slide showcases the physical device and a series of color-coded test cartridges for various conditions (COVID-19, HbA1c, D-Dimer, etc.).present_solution
Open slide detailBeat · Solution (Provide relief)
16
The visual shows four distinct test strips (INR, D-Dimer, SARS CoV-2 Ab, SARS CoV-2 Ag) to demonstrate the 'common architecture' claim.present_solution
17
The slide uses a numbered process flow (1-8) to explain the technical mechanism of the assay.present_solution
19
The chart uses a bar-vertical format to show relative pricing, with LumiraDx POC positioned as significantly cheaper than other POC solutions.present_solution
20
The diagram uses concentric circles to represent layers of IP protection (Manufacturing, Assays, Microfluidic Strip, Instrument).present_solution
21
The slide uses a horizontal arrow at the bottom to represent the strategic shift toward 'Decentralization'.present_solution
22
The slide displays the physical device on the right and a row of 10 distinct test cartridges on the left, representing the product pipeline.present_solution
24
The slide uses a scatter plot to demonstrate method comparison between LumiraDx and a laboratory reference (bioMérieux Vidas).present_solution
25
The slide uses two line charts to compare positivity rates across different test methods (LumiraDx, PCR, Other POC) over time, segmented by COVID-19 variants.show_traction
Open slide detailBeat · Evidence
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.present_solution
Open slide detailBeat · Evidence
27
The slide uses a blue dashed box to highlight key differentiators for the company's product.compare_peers
Open slide detailBeat · Evidence
28
The scatter plot shows a high correlation (R^2 = 0.9868) between the two testing methods.analyze_data
Open slide detailBeat · Evidence
29
The slide uses a process diagram to explain the workflow and a combination of line charts and a comparison table to demonstrate performance feasibility.show_traction
Open slide detailBeat · Evidence
30
The chart shows a significant drop-off in the TB care cascade, framing the opportunity for a POC test to improve linkage to care.show_traction
Open slide detailBeat · Evidence
31
The slide illustrates a 3-step process: Prep Sample, Load & Run, and Report Results, with a timeline of 1 minute for prep and 2-12 minutes for results.present_solution
32
Uses a visual 'before/after' style comparison with red X marks to indicate legacy/displaced systems.present_solution
33
The table shows a progression from Year 1 to Year 2, and a second Year 2 column, likely representing a ramp-up or optimization scenario.analyze_data
34
The slide uses a product-centric layout to demonstrate market readiness and addressable market size for a portfolio of diagnostic tests.show_traction
35
The slide uses a Gantt-style chart to visualize development stages (Concept to Regulatory) for multiple product lines.plan_implementation
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).present_solution
37
The slide emphasizes the breadth of the diagnostic menu available on a single hardware platform.present_solution
38
The chart uses a waterfall-like structure to show market segments, though it is not a true waterfall as the bars do not sum to the total.size_opportunity
39
The slide uses a horizontal progression to illustrate the shift from centralized lab testing to decentralized home testing.present_solution
40
The slide uses a mix of bulleted lists and visual icons to categorize the technology's deployment across different operational models.present_solution
41
The slide uses a process-like flow to categorize product applications.present_solution
42
The diagram is a circular process flow showing the integration of hardware, software, and pharmacy services.present_solution
44
The slide highlights current reach and future expansion plans into major diagnostics markets.show_traction
45
The slide uses a matrix structure to segment the market and align products/partners to each segment.plan_implementation
46
Includes a table of use cases and a bar chart of instrument counts.illustrate_case
Open slide detailLoop · Quick Win Big Bet
47
Uses a before-and-after framing to demonstrate operational efficiency gains.illustrate_case
Open slide detailLoop · Quick Win Big Bet
48
Uses a three-column process flow to contrast past problems with current solution and future potential.illustrate_case
Open slide detailLoop · Quick Win Big Bet
49
The slide displays the LumiraDx point-of-care diagnostic platform alongside a row of various test cartridges.front_matter
50
The chart uses a waterfall structure to represent revenue segmentation across different medical diagnostic categories.analyze_data
51
The table tracks cumulative instruments, manufacturing capacity, geographic reach, and revenue breakdowns.analyze_data
53
The slide displays the LumiraDx platform hardware alongside a row of 10 distinct test cartridges (SARS-CoV-2 variants, HbA1c, D-Dimer, INR, NT-proBNP, CRP).appendix
54
The slide uses a two-column layout to contrast Western healthcare policy shifts with global health development initiatives.establish_context